> What matters is that the doctor or hospital is also in Germany. Given that ~90% of cancer research is funded in the United States [0], that might work for es

> What matters is that the doctor or hospital is also in Germany. Given that ~90% of cancer research is funded in the United States [0], that might work for established therapies but anything on the cutting edge might be hard to get? According to this article from MGH, cutting edge immunotherapies cost ~$1M per patient: http://protomag.com/articles/solid-tumor-barrier http://protomag.com/articles/solid-tumor-barrier And this one demonstrates the delays in their availability in Europe. Sucks big time for the people currently needing treatment: https://www.bloomberg.com/news/articles/2018-09-12/novartis-faces-price-tussle-in-europe-after-cancer-breakthrough https://www.bloomberg.com/news/articles/2018-09-12/novartis-... [0] #62 Peter Attia M.D. podcast with Keith Flaherty MGH